Literature DB >> 27330467

External dacryocystorhinostomy outcomes in patients with a history of dacryocystitis.

Daniel R Lefebvre1, Sonya Dhar2, Irene Lee3, Felicia Allard4, Suzanne K Freitag1.   

Abstract

PURPOSE: To investigate nonidiopathic causes of external dacryocystorhinostomy (DCR) failure.
METHODS: The medical records of all patients with acute or chronic dacryocystitis who underwent external dacryocystorhinostomy performed by the senior author over a 5-year period were retrospectively reviewed, with attention to microbiology, pathology, and associated medical and history.
RESULTS: A total of 52 lacrimal systems of 49 patients were included, with a minimum follow-up of 2 months (average, 15.5 months). Surgical success was achieved in 42 systems (87%). Of 7 failures, 6 had a condition potentially associated with an increased risk of failure, including MRSA infection, Gram-negative infection, rhinosinusitis, lymphoma, inflammatory bowel disease, and early loss of lacrimal stents.
CONCLUSIONS: External DCR is a successful procedure for the treatment of nasolacrimal obstruction associated with dacryocystitis. Various factors may affect surgical success, and awareness of these factors may enable better patient counseling and surgical planning.

Entities:  

Mesh:

Year:  2015        PMID: 27330467      PMCID: PMC4902648          DOI: 10.5693/djo.01.2014.08.001

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  34 in total

1.  Chronic sinonasal disease in patients with inflammatory bowel disease.

Authors:  David T Book; Timothy L Smith; Justin P McNamar; Kia Saeian; David G Binion; Robert J Toohill
Journal:  Am J Rhinol       Date:  2003 Mar-Apr

2.  Microbiological patterns of chronic dacryocystitis.

Authors:  Badri Prasad Badhu; Balman S Karki; Basudha Khanal; Sunu Dulal; Hrishikesh Das
Journal:  Ophthalmology       Date:  2006-12       Impact factor: 12.079

3.  Study on the effectiveness of antibiotic prophylaxis in external dacryocystorhinostomy: a review of 697 cases.

Authors:  Sergio Pinar-Sueiro; Roberto-Víctor Fernández-Hermida; Ane Gibelalde; Lorea Martínez-Indart
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 Nov-Dec       Impact factor: 1.746

4.  Study of intranasal ostium external dacryocystorhinostomy.

Authors:  J V Linberg; R L Anderson; R M Bumsted; R Barreras
Journal:  Arch Ophthalmol       Date:  1982-11

5.  The pathogenesis and treatment of lacrimal obstruction: The value of lacrimal sac and bone analysis.

Authors:  Dan DeAngelis; Jeff Hurwitz; James Oestreicher; David Howarth
Journal:  Orbit       Date:  2001-09

6.  Acquired lacrimal sac fistula after incision and drainage for dacryocystitis: a multicenter study.

Authors:  Rhonda V Barrett; Dale R Meyer
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2009 Nov-Dec       Impact factor: 1.746

7.  The microbiologic spectrum of dacryocystitis: a national study of acute versus chronic infection.

Authors:  David M Mills; Marc G Bodman; Dale R Meyer; Asa D Morton
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2007 Jul-Aug       Impact factor: 1.746

8.  Comparison of external dacryocystorhinostomy with nonlaser endonasal dacryocystorhinostomy.

Authors:  Peter J Dolman
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

9.  Factors affecting the success rate of open lacrimal surgery.

Authors:  M J Walland; G E Rose
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

10.  Crohn's disease affecting the nasal mucosa.

Authors:  W J Kinnear
Journal:  J Otolaryngol       Date:  1985-12
View more
  2 in total

1.  Frequency of Bacterial Samples from Patients with Chronic Acquired Nasolacrimal Duct Obstruction.

Authors:  Jasmin Zvornicanin
Journal:  Med Arch       Date:  2017-02-05

Review 2.  A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options.

Authors:  Jason Bacharach; Wendy W Lee; Andrew R Harrison; Thomas F Freddo
Journal:  Eye (Lond)       Date:  2021-04-29       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.